Skip to content

Evaluation of the Child and Family Traumatic Stress Intervention

Evaluation of the Child and Family Traumatic Stress Intervention

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01031615
Acronym
CFTSI
Enrollment
112
Registered
2009-12-14
Start date
2005-10-31
Completion date
2009-09-30
Last updated
2011-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder

Keywords

School age children and adolescents exposed to a potentially traumatic event

Brief summary

The purpose of this study is to determine the efficacy of the Child and Family Traumatic Stress Intervention (CFTSI) in preventing the development of Posttraumatic Stress Disorder (PTSD) when implemented within 30 days of a potentially traumatic event.

Interventions

BEHAVIORALChild and Family Traumatic Stress Interv (CFTSI)

4 sessions involving both the target child and a parent/caregiver

BEHAVIORALPsychoeducational Comparison

4 individually focused sessions including psychoeducation and relaxation.

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Youth exposed to a potentially traumatic event within the last 30 days who have one new symptom on the Posttraumatic Checklist (PCL)

Exclusion criteria

* Already receiving mental health treatment * Autism or Developmental Disability * Diagnosed with psychosis or bipolar disorder * Non-english speaking

Design outcomes

Primary

MeasureTime frame
UCLA Posttraumatic Reaction Index (PTSD-RI)3 months post-intervention

Secondary

MeasureTime frame
Trauma Symptom Checklist for Children (TSCC)3 Months post-intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026